Project Inform invites volunteers for new projects
Project Inform is looking for volunteers to staff three very different projects over the next few months. If you are interested in any of these or any other volunteer activities with Project Inform please contact Emily Mariko-Sanders or 415-580-7306. Help-4-Hep Mailing Event Tuesday/Wednesday September 24–25, 1–4pm…Read More
August 26, 2013, Washington, DC (reprinted from ACTF and NASTAD) The ACTF has a long history of working collaboratively with ViiV Healthcare to provide ADAPs access to discounted pricing on its HIV drugs. The special pricing of Tivicay, available to all state ADAPs, is in addition to…Read More
Project Inform holds annual Think Tank on scaling up risk-based hepatitis C screening
On September 17 and 18, 2013, Project Inform will convene a Think Tank focusing on hepatitis C: “Scaling-Up Risk-Based Hepatitis C Screening in the United States”. Hosting 30 national, state and local health officials, policy experts, doctors and community advocates, Project Inform will utilize the Think…Read More
FDA approves new integrase inhibitor dolutegravir (Tivicay)
The Food and Drug Administration (FDA) announced August 12, 2013 that they approved a new integrase inhibitor against HIV, called dolutegravir (Tivicay). The drug works by keeping HIV from integrating into human DNA, which then prevents the virus from reproducing. The FDA approval is based upon the…Read More
Improving the nation’s response to identifying the nearly 240,000 Americans who don’t know they have HIV and get them into care is a key goal of the National HIV/AIDS Strategy. The FDA has taken another step towards that goal by approving the first rapid test that…Read More
by Mark Mascolini, National AIDS Treatment Advocacy Project 7th International AIDS Society Conference, Kuala Lumpur, June 2013: Each additional antiretroviral therapy (ART) regimen taken was independently associated with 0.011 g/cm(2) lower femoral neck bone mineral density (BMD) and 0.015 g/cm(2) lower lumbar spine BMD in a…Read More
by Mark Mascolini, National AIDS Treatment Advocacy Project 7th International AIDS Society Conference, Kuala Lumpur, June 2013: Every year 1 in 5 middle-aged or older gay men in an Australian cohort became infected with a human papillomavirus (HPV) genotype covered by the currently available quadrivalent HPV…Read More